Related Experiment Videos
Comparative efficacy of ampicillin and trimethoprim-sulfamethoxazole in otitis media
Insights
This study found ampicillin and trimethoprim-sulfamethoxazole (TMP-SMX) equally effective for treating acute otitis media in children. TMP-SMX showed a low incidence of side effects, making it a viable treatment option.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Acute otitis media (AOM) is a common childhood infection.
- Antibiotic resistance necessitates evaluating alternative treatments for AOM.
- Ampicillin and trimethoprim-sulfamethoxazole are commonly used antibiotics for AOM.
Purpose of the Study:
- To compare the clinical effectiveness of ampicillin and trimethoprim-sulfamethoxazole (TMP-SMX) in treating acute otitis media in children.
- To assess the safety and side effect profiles of both antibiotic regimens.
Main Methods:
- A double-blind, randomized study involving 79 children with AOM.
- Participants received either ampicillin or TMP-SMX, with dosage adjusted for weight.
- Clinical outcomes and adverse events were monitored.
Main Results:
- No statistically significant difference in clinical outcomes was observed between the ampicillin and TMP-SMX treatment groups.
- TMP-SMX was associated with a notably low incidence of undesirable side effects.
Conclusions:
- Both ampicillin and TMP-SMX are effective treatments for acute otitis media in children.
- TMP-SMX presents a favorable safety profile with minimal side effects for pediatric AOM treatment.
Abstract:
Seventy-nine children with acute otitis media were the subjects in a study designed to compare the effectiveness of ampicillin and trimethoprim-sulfamethoxazole in this infection. They received either of these two agents according to a double-blind randomized procedure that also took the child's weight into account. No significant difference was found in the clinical outcome between the two treatment regimens. Undesirable side effects from TMP-SMX were notably few.